Quantcast
The first installment of our new predictive index shows that dealmakers expect overall M&A to increase, with health care outperforming the overall market READ MORE 

SLIDESHOW

ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld

Watercooler

GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market

Roundtable

Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Compuware Rejects $2.3B Elliott Offer

Instead, Compuware will implement a cost-reduction plan and potentially spin off Covisint

Software technology company Compuware Corp. (Nasdaq: CPWR) has rejected hedge fund Elliott Management Corp.’s $2.3 billion proposal to buy the company, saying that instead it will work on a cost-reduction plan to provide shareholder returns.

Elliott offered to pay $11 per share for Compuware in December, but Compuware has expressed it thinks that price significantly undervalues the company. Compuware’s shares opened at $10.86 and were trading at $11.41 mid-day after the announcement.

Detroit-based Compuware’s plan includes eliminating $60 million in company costs over the next three years, spinning off cloud platform Covisint and implementing a plan to return capital to shareholders. Compuware filed paperwork for a possible initial public offering for Covisent in December. 

 

For more information on related topics, visit the following: